Annual Shareholders Equity
$46.67 B
-$12.68 B-21.36%
31 December 2023
Summary:
Novartis AG annual stockholders equity is currently $46.67 billion, with the most recent change of -$12.68 billion (-21.36%) on 31 December 2023. During the last 3 years, it has fallen by -$9.93 billion (-17.55%). NVS annual shareholders equity is now -40.64% below its all-time high of $78.61 billion, reached on 31 December 2018.NVS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$43.32 B
+$1.58 B+3.80%
30 September 2024
Summary:
Novartis AG quarterly stockholders equity is currently $43.32 billion, with the most recent change of +$1.58 billion (+3.80%) on 30 September 2024. Over the past year, it has increased by +$5.15 billion (+13.50%). NVS quarterly shareholders equity is now -45.00% below its all-time high of $78.76 billion, reached on 30 June 2015.NVS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.4% | +13.5% |
| 3 y3 years | -17.6% | -23.7% |
| 5 y5 years | -40.6% | -17.5% |
NVS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.0% | at low | -36.0% | +13.5% |
| 5 y | 5 years | -40.6% | at low | -36.0% | +13.5% |
| alltime | all time | -40.6% | +104.5% | -45.0% | +110.8% |
Novartis AG Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $43.32 B(+3.8%) |
| June 2024 | - | $41.73 B(+5.2%) |
| Mar 2024 | - | $39.67 B(-15.0%) |
| Dec 2023 | $46.67 B(-21.4%) | $46.67 B(+22.3%) |
| Sept 2023 | - | $38.16 B(-26.4%) |
| June 2023 | - | $51.85 B(-0.4%) |
| Mar 2023 | - | $52.06 B(-12.3%) |
| Dec 2022 | $59.34 B(-12.3%) | $59.34 B(-2.4%) |
| Sept 2022 | - | $60.82 B(-3.3%) |
| June 2022 | - | $62.92 B(+2.3%) |
| Mar 2022 | - | $61.54 B(-9.0%) |
| Dec 2021 | $67.66 B(+19.5%) | $67.66 B(+19.2%) |
| Sept 2021 | - | $56.77 B(+5.0%) |
| June 2021 | - | $54.04 B(+7.0%) |
| Mar 2021 | - | $50.52 B(-10.7%) |
| Dec 2020 | $56.60 B(+2.0%) | $56.60 B(+3.9%) |
| Sept 2020 | - | $54.48 B(+1.2%) |
| June 2020 | - | $53.81 B(+5.7%) |
| Mar 2020 | - | $50.90 B(-8.2%) |
| Dec 2019 | $55.47 B(-29.4%) | $55.47 B(+5.6%) |
| Sept 2019 | - | $52.52 B(+2.1%) |
| June 2019 | - | $51.43 B(+8.9%) |
| Mar 2019 | - | $47.23 B(-39.9%) |
| Dec 2018 | $78.61 B(+6.0%) | $78.61 B(+0.9%) |
| Sept 2018 | - | $77.94 B(+1.5%) |
| June 2018 | - | $76.81 B(+8.0%) |
| Mar 2018 | - | $71.10 B(-4.1%) |
| Dec 2017 | $74.17 B(-0.9%) | $74.17 B(+2.6%) |
| Sept 2017 | - | $72.31 B(+3.4%) |
| June 2017 | - | $69.92 B(+3.5%) |
| Mar 2017 | - | $67.59 B(-9.7%) |
| Dec 2016 | $74.83 B(-2.9%) | $74.83 B(-0.2%) |
| Sept 2016 | - | $74.98 B(+3.5%) |
| June 2016 | - | $72.46 B(+0.9%) |
| Mar 2016 | - | $71.81 B(-6.8%) |
| Dec 2015 | $77.05 B(+8.9%) | $77.05 B(+0.4%) |
| Sept 2015 | - | $76.71 B(-2.6%) |
| June 2015 | - | $78.76 B(+3.1%) |
| Mar 2015 | - | $76.38 B(+7.9%) |
| Dec 2014 | $70.77 B(-4.8%) | $70.77 B(-0.8%) |
| Sept 2014 | - | $71.34 B(+1.4%) |
| June 2014 | - | $70.39 B(+0.3%) |
| Mar 2014 | - | $70.21 B(-5.6%) |
| Dec 2013 | $74.34 B(+7.5%) | $74.34 B(+3.2%) |
| Sept 2013 | - | $72.05 B(+3.7%) |
| June 2013 | - | $69.49 B(+3.7%) |
| Mar 2013 | - | $67.03 B(-3.0%) |
| Dec 2012 | $69.14 B | $69.14 B(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $67.08 B(+4.6%) |
| June 2012 | - | $64.13 B(+1.6%) |
| Mar 2012 | - | $63.10 B(-4.2%) |
| Dec 2011 | $65.84 B(+4.2%) | $65.84 B(-0.4%) |
| Sept 2011 | - | $66.14 B(-1.4%) |
| June 2011 | - | $67.09 B(+2.7%) |
| Mar 2011 | - | $65.34 B(+3.4%) |
| Dec 2010 | $63.20 B(+10.1%) | $63.20 B(-4.6%) |
| Sept 2010 | - | $66.22 B(+18.6%) |
| June 2010 | - | $55.82 B(+1.1%) |
| Mar 2010 | - | $55.22 B(-3.8%) |
| Dec 2009 | $57.39 B(+14.1%) | $57.39 B(+7.6%) |
| Sept 2009 | - | $53.31 B(+5.6%) |
| June 2009 | - | $50.49 B(+9.2%) |
| Mar 2009 | - | $46.23 B(-8.1%) |
| Dec 2008 | $50.29 B(+2.2%) | $50.29 B(-0.9%) |
| Sept 2008 | - | $50.74 B(-1.7%) |
| June 2008 | - | $51.60 B(+4.7%) |
| Mar 2008 | - | $49.27 B(+0.1%) |
| Dec 2007 | $49.22 B(+19.7%) | $49.22 B(-0.5%) |
| Sept 2007 | - | $49.49 B(+13.3%) |
| June 2007 | - | $43.66 B(+7.8%) |
| Mar 2007 | - | $40.50 B(-1.5%) |
| Dec 2006 | $41.11 B(+24.6%) | $41.11 B(+6.5%) |
| Sept 2006 | - | $38.59 B(+3.8%) |
| June 2006 | - | $37.16 B(+10.1%) |
| Mar 2006 | - | $33.75 B(+2.3%) |
| Dec 2005 | $32.99 B(+5.8%) | $32.99 B(+3.9%) |
| Sept 2005 | - | $31.74 B(+4.4%) |
| June 2005 | - | $30.39 B(+3.2%) |
| Mar 2005 | - | $29.46 B(-5.5%) |
| Dec 2004 | $31.18 B(+2.5%) | $31.18 B(+0.6%) |
| Sept 2004 | - | $30.99 B(+2.8%) |
| June 2004 | - | $30.16 B(+2.8%) |
| Mar 2004 | - | $29.32 B(-3.6%) |
| Dec 2003 | $30.43 B(+7.6%) | $30.43 B(+7.0%) |
| Sept 2003 | - | $28.44 B(+7.7%) |
| June 2003 | - | $26.42 B(-5.7%) |
| Mar 2003 | - | $28.01 B(-0.9%) |
| Dec 2002 | $28.27 B(+10.9%) | $28.27 B(+9.3%) |
| Sept 2002 | - | $25.87 B(-7.4%) |
| June 2002 | - | $27.94 B(+9.6%) |
| Dec 2001 | $25.50 B(+11.6%) | $25.50 B(+24.1%) |
| June 2001 | - | $20.55 B(-10.0%) |
| Dec 2000 | $22.84 B(-2.3%) | $22.84 B(-1.4%) |
| June 2000 | - | $23.16 B |
| Dec 1999 | $23.37 B(+2.4%) | - |
| Dec 1998 | $22.82 B | - |
FAQ
- What is Novartis AG annual stockholders equity?
- What is the all time high annual shareholders equity for Novartis AG?
- What is Novartis AG annual shareholders equity year-on-year change?
- What is Novartis AG quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Novartis AG?
- What is Novartis AG quarterly shareholders equity year-on-year change?
What is Novartis AG annual stockholders equity?
The current annual shareholders equity of NVS is $46.67 B
What is the all time high annual shareholders equity for Novartis AG?
Novartis AG all-time high annual stockholders equity is $78.61 B
What is Novartis AG annual shareholders equity year-on-year change?
Over the past year, NVS annual stockholders equity has changed by -$12.68 B (-21.36%)
What is Novartis AG quarterly stockholders equity?
The current quarterly shareholders equity of NVS is $43.32 B
What is the all time high quarterly shareholders equity for Novartis AG?
Novartis AG all-time high quarterly stockholders equity is $78.76 B
What is Novartis AG quarterly shareholders equity year-on-year change?
Over the past year, NVS quarterly stockholders equity has changed by +$5.15 B (+13.50%)